MoneyWorks4Me

Lactose India - Quaterly Results

14 Feb 2024 Evaluate
An increase of about 91.59% to Rs. 325.99 millions in the topline was observed for the quarter ended December 2023. The topline stood at Rs. 170.15 millions during the similar quarter previous year.Net Profit for the quarter ended December 2023 zoomed to 1713.10% from Rs. 1.45 millions to Rs. 26.29  millions.Operating Profit saw a handsome growth to 60.06 millions from 28.90 millions in the quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 325.99 170.15 91.59 844.92 398.07 112.25 657.96 459.39 43.22
Other Income 2.81 1.59 76.73 8.19 5.83 40.48 7.29 5.79 25.91
PBIDT 60.06 28.90 107.82 137.08 79.54 72.34 121.85 128.40 -5.10
Interest 12.14 15.54 -21.88 40.80 41.10 -0.73 60.36 51.16 17.98
PBDT 47.92 13.36 258.68 96.28 38.44 150.47 61.49 77.24 -20.39
Depreciation 11.97 11.70 2.31 35.86 34.97 2.55 46.85 45.59 2.76
PBT 35.95 1.66 2065.66 60.42 3.47 1641.21 14.64 31.65 -53.74
TAX 9.66 0.21 4500.00 16.50 0.28 5792.86 2.56 7.16 -64.25
Deferred Tax 3.67 -0.18 -2138.89 6.41 0.30 2036.67 0.77 1.46 -47.26
PAT 26.29 1.45 1713.10 43.92 3.19 1276.80 12.08 24.49 -50.67
Equity 125.89 125.89 0.00 125.89 125.89 0.00 125.89 125.89 0.00
PBIDTM(%) 18.42 16.99 8.47 16.22 19.98 -18.80 18.52 27.95 -33.74
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..